900000000000508004: Great Britain English language reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Language type reference set (foundation metadata concept)\English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)\GB English

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
GB English	Is a	English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	acceptabilityId
15q14 microdeletion syndrome is a recently described syndrome characterised by developmental delay, short stature and facial dysmorphism.	Preferred (foundation metadata concept)
15q24 deletion	Acceptable (foundation metadata concept)
15q24 microdeletion	Preferred (foundation metadata concept)
15q24 microdeletion syndrome	Acceptable (foundation metadata concept)
15q26 deletion syndrome	Acceptable (foundation metadata concept)
15q26.3 microdeletion syndrome	Acceptable (foundation metadata concept)
16	Preferred (foundation metadata concept)
16 (AJCC)	Acceptable (foundation metadata concept)
16 (UICC)	Acceptable (foundation metadata concept)
16 (qualifier value)	Preferred (foundation metadata concept)
16 Personality factor questionnaire	Preferred (foundation metadata concept)
16 Personality factor questionnaire (assessment scale)	Preferred (foundation metadata concept)
16 alpha-hydroxydehydroepiandrosterone	Preferred (foundation metadata concept)
16 alpha-hydroxydehydroepiandrosterone (substance)	Preferred (foundation metadata concept)
16 alpha-hydroxydehydroepiandrosterone sulfate	Preferred (foundation metadata concept)
16 alpha-hydroxydehydroepiandrosterone sulfate (substance)	Preferred (foundation metadata concept)
16 alpha-hydroxydehydroepiandrosterone sulphate	Acceptable (foundation metadata concept)
16 alpha-hydroxyestrone	Preferred (foundation metadata concept)
16 alpha-hydroxyestrone (substance)	Preferred (foundation metadata concept)
16 times a day	Acceptable (foundation metadata concept)
16-alpha-Hydroxypregnenolone	Preferred (foundation metadata concept)
16-alpha-Hydroxypregnenolone (substance)	Preferred (foundation metadata concept)
16-alpha-Hydroxysteroid dehydrogenase	Preferred (foundation metadata concept)
16-alpha-Hydroxysteroid dehydrogenase (substance)	Preferred (foundation metadata concept)
16-alpha-hydroxyprogesterone dehydratase	Acceptable (foundation metadata concept)
16-alpha-hydroxyprogesterone dehydratase	Preferred (foundation metadata concept)
16-alpha-hydroxyprogesterone dehydratase (substance)	Preferred (foundation metadata concept)
16-dehydroprogesterone hydratase	Preferred (foundation metadata concept)
16-dehydroprogesterone hydratase (substance)	Preferred (foundation metadata concept)
16-hydroxysteroid epimerase	Preferred (foundation metadata concept)
16-hydroxysteroid epimerase (substance)	Preferred (foundation metadata concept)
16-ketoandrostenediol	Acceptable (foundation metadata concept)
16-methoxy-2,3-dihydro-3-hydroxytabersonine N-methyltransferase	Preferred (foundation metadata concept)
16-methoxy-2,3-dihydro-3-hydroxytabersonine N-methyltransferase (substance)	Preferred (foundation metadata concept)
16-oxoandrostenediol	Preferred (foundation metadata concept)
16-oxoandrostenediol (substance)	Preferred (foundation metadata concept)
16.1	Preferred (foundation metadata concept)
16.1 (qualifier value)	Preferred (foundation metadata concept)
16.2	Preferred (foundation metadata concept)
16.2 (qualifier value)	Preferred (foundation metadata concept)
16.58	Preferred (foundation metadata concept)
16.58 (qualifier value)	Preferred (foundation metadata concept)
16.7	Preferred (foundation metadata concept)
16.7 (qualifier value)	Preferred (foundation metadata concept)
16.8	Preferred (foundation metadata concept)
16.8 (qualifier value)	Preferred (foundation metadata concept)
16/16	Preferred (foundation metadata concept)
16/22	Preferred (foundation metadata concept)
160	Preferred (foundation metadata concept)
160 (qualifier value)	Preferred (foundation metadata concept)
1600	Preferred (foundation metadata concept)
1600 (qualifier value)	Preferred (foundation metadata concept)
16000	Preferred (foundation metadata concept)
16000 (qualifier value)	Preferred (foundation metadata concept)
162	Preferred (foundation metadata concept)
162 (qualifier value)	Preferred (foundation metadata concept)
1627 Burgas	Preferred (foundation metadata concept)
164-Yb	Acceptable (foundation metadata concept)
165	Preferred (foundation metadata concept)
165 (qualifier value)	Preferred (foundation metadata concept)
166	Preferred (foundation metadata concept)
166 (qualifier value)	Preferred (foundation metadata concept)
166-Ho	Acceptable (foundation metadata concept)
166-Yb	Acceptable (foundation metadata concept)
166.667	Preferred (foundation metadata concept)
166.667 (qualifier value)	Preferred (foundation metadata concept)
16600	Preferred (foundation metadata concept)
16600 (qualifier value)	Preferred (foundation metadata concept)
16667	Preferred (foundation metadata concept)
16667 (qualifier value)	Preferred (foundation metadata concept)
1667	Preferred (foundation metadata concept)
1667 (qualifier value)	Preferred (foundation metadata concept)
167	Preferred (foundation metadata concept)
167 (qualifier value)	Preferred (foundation metadata concept)
168	Preferred (foundation metadata concept)
168 (qualifier value)	Preferred (foundation metadata concept)
1680	Preferred (foundation metadata concept)
1680 (qualifier value)	Preferred (foundation metadata concept)
16800	Preferred (foundation metadata concept)
16800 (qualifier value)	Preferred (foundation metadata concept)
169-Er	Acceptable (foundation metadata concept)
169-Hf	Acceptable (foundation metadata concept)
169-Yb	Acceptable (foundation metadata concept)
16G	Preferred (foundation metadata concept)
16G (qualifier value)	Preferred (foundation metadata concept)
16PF - Personality factor questionnaire	Acceptable (foundation metadata concept)
16p partial trisomy syndrome	Preferred (foundation metadata concept)
16p partial trisomy syndrome (disorder)	Preferred (foundation metadata concept)
16p11.2 deletion syndrome	Acceptable (foundation metadata concept)
16p11.2-p12.2 microdeletion syndrome is a recently described syndrome characterised by developmental delay and facial dysmorphism.	Preferred (foundation metadata concept)
16p11.2p12.2 microdeletion syndrome	Preferred (foundation metadata concept)
16p11.2p12.2 microdeletion syndrome (disorder)	Preferred (foundation metadata concept)
16p11.2p12.2 microduplication syndrome	Preferred (foundation metadata concept)
16p11.2p12.2 microduplication syndrome (disorder)	Preferred (foundation metadata concept)
16p11.2p12.2 microduplication syndrome is a rare chromosomal anomaly syndrome resulting from the partial duplication of the short arm of chromosome 16 with a highly variable phenotype typically characterised by developmental/psychomotor delay (particularly of speech), intellectual disability, autism spectrum disorder and/or obsessive and repetitive behaviour, behavioural problems (such as aggression and outbursts), dysmorphic facial features (triangular face, deep set eyes, broad and prominent nasal bridge, upslanting or narrow palpebral features, hypertelorism). Additionally, finger/hand anomalies, short stature, microcephaly and slender build are frequently described.	Preferred (foundation metadata concept)
16p12.1p12.3 triplication syndrome	Preferred (foundation metadata concept)
16p12.1p12.3 triplication syndrome (disorder)	Preferred (foundation metadata concept)
16p12.1p12.3 triplication syndrome is a rare chromosomal anomaly syndrome resulting from the partial triplication of the short arm of chromosome 16 characterised by global developmental delay, pre- or post-natal growth delay and distinctive craniofacial features, including short palpebral fissures, epicanthal folds, bulbous nose, thin upper vermillion border, apparently low-set ears and large ear lobes. Variable clinical features that have been reported include congenital heart disease, genitourinary abnormalities, visual anomalies or, less commonly, infantile hepatic disease. Patients are also reported to have tapered fingers.	Preferred (foundation metadata concept)
16p12.2 microdeletion	Acceptable (foundation metadata concept)
16p12.2 microdeletion syndrome	Preferred (foundation metadata concept)
16p12.2 microdeletion syndrome (disorder)	Preferred (foundation metadata concept)

Start Previous Page 73 of 13273 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001112010	Great Britain English language reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001113017	GB English	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001114011	Great Britain English language reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)